{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:53:31Z","timestamp":1771653211953,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T00:00:00Z","timestamp":1624752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"St. Josef- und St. Elisabeth-Hospital gGmbH"},{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00415-021-10661-z","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T12:02:16Z","timestamp":1624795336000},"page":"4374-4375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8217-6063","authenticated-orcid":false,"given":"Ann-Kathrin","family":"Kogel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,27]]},"reference":[{"key":"10661_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-224740","author":"S Micallef","year":"2018","unstructured":"Micallef S, Galea R (2018) CMV encephalitis in an immune-competent patient. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2018-224740","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10661_CR2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2174\/187152611797636703","volume":"11","author":"SA Ross","year":"2011","unstructured":"Ross SA, Novak Z, Pati S, Boppana SB (2011) Diagnosis of cytomegalovirus infections. Infect Disord Drug Targets 11(5):466\u2013474","journal-title":"Infect Disord Drug Targets"},{"key":"10661_CR3","doi-asserted-by":"publisher","DOI":"10.12890\/2019_001046","author":"M Lima","year":"2019","unstructured":"Lima M, Farias LA, da Ponte MF, Furdato LE (2019) Self-limited cytomegalovirus infection during natalizumab treatment for multiple sclerosis. EJCRIM. https:\/\/doi.org\/10.12890\/2019_001046","journal-title":"EJCRIM"},{"issue":"6","key":"10661_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/1352458516688350","volume":"23","author":"M Clerico","year":"2017","unstructured":"Clerico M, De Mercanti S, Artusi CA, Durelli L, Naismith RT (2017) Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab. Mult Scler 23(6):874\u2013876. https:\/\/doi.org\/10.1177\/1352458516688350 (Epub 2017 Feb 1)","journal-title":"Mult Scler"},{"key":"10661_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1212\/CPJ.0000000000000238","volume":"6","author":"RJ Fox","year":"2016","unstructured":"Fox RJ, Chan A, Gold R, Phillips JT, Selmaj K, Chang I, Novas M, Rana J, Marantz JL (2016) Characterizing absolute lymphocyte count profiles in dimethyl fumarate\u2013treated patients with MS Patient management considerations. Neurol Clin Pract 6:220\u2013229","journal-title":"Neurol Clin Pract"},{"key":"10661_CR6","doi-asserted-by":"publisher","first-page":"e1724","DOI":"10.1212\/WNL.0000000000007262","volume":"92","author":"D Mehta","year":"2019","unstructured":"Mehta D, Miller C, Arnold DL et al (2019) Effect of dimethyl fumarate on lymphocytes in RRMS: implications for clinical practice. Neurology 92:e1724\u2013e1738. https:\/\/doi.org\/10.1212\/WNL.0000000000007262 ((Published Online before print March 27, 2019))","journal-title":"Neurology"},{"key":"10661_CR7","unstructured":"Gold R, Giovannoni G, Phillips J, Bar-Or A, Fox R, Mokliatchouk O, Parks B, Miller C, Kapadia S (2020) FC02.05\u2014safety and efficacy in patients treated with dimethyl fumarate and followed for 13 years: final results of ENDORSE. MSVirtual2020. Held online 11\u201313.09.2020"},{"issue":"12","key":"10661_CR8","doi-asserted-by":"publisher","first-page":"1104.e1","DOI":"10.1016\/j.cmi.2015.07.019","volume":"21","author":"M Bodro","year":"2015","unstructured":"Bodro M, Sanclemente G, Lipperheide I, Allali M, Marco F, Bosch J, Cofan F, Ricart MJ, Esforzado N, Oppenheimer F, Moreno A, Cervera C (2015) Impact of urinary tract infections on short-term kidney graft outcome. Clin Microbiol Infect 21(12):1104.e1\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2015.07.019 (Epub 2015 Jul 31)","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10661-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10661-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10661-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T15:46:29Z","timestamp":1633967189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10661-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,27]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10661"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10661-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,27]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AK has nothing to report. RG received honoraria for lecturing and advisory boards from Biogen. His institution receives grant support for IIT studies. RS has received consulting and speakers honoraria from Biogen Idec GmBH and Roche Pharma AG & has received research scientific grant support from Novartis Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}